Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

Oral VRL offers easier administration, better quality of life, and cost saving. This study aimed to evaluate the treatment efficacy in terms of tumor response of the two formulations of vinorelbine (VRL, oral and IV) in combination with epirubicin (EPI); and the effect of EPI co-administration on VR...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Chemother Pharmacol
Main Authors: Huang, Liang, Wang, Xiaojia, Zhou, Liheng, Di, Lijun, Zheng, Hongyu, Jiang, Zefei, Wang, Yongsheng, Song, Xiangqun, Feng, Jifeng, Yu, Shiying, Liu, Yunpeng, Zheng, Hong, Shen, Kunwei, Tong, Zhongsheng, Shao, Zhimin
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://ncbi.nlm.nih.gov/pubmed/31838561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-04000-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items